Introduction of cancer, Types of cancer, Causes of cancer, Signs and Symptoms, Diagnosis, Treatment of cancer, Prevention of cancer, Conclusion of cancer
Cancer and its types, all tumours are not cancer, cancer, diagnosis of cancer, how cancer differ, how cancer spread, how cancer start, how normal cells act
Cancer and its types, all tumours are not cancer, cancer, diagnosis of cancer, how cancer differ, how cancer spread, how cancer start, how normal cells act
Cancer is an abnormal growth of cells caused by multiple changes in gene expression leading to
dysregulated balance of cell proliferation and cell death and ultimately evolving into a population
of cells that can invade tissues and metastasize to distant sites, causing significant morbidity and,
if untreated, death of the host.
It is characterized by alterations in the expression of multiple genes, leading to dysregulation of the normal cellular program for cell division and cell differentiation. This results in an imbalance of cell replication and cell death that favours the growth of a tumour cell population. Tumour is an abnormal lump or growth of cells. When the cells in the tumour are normal, it is benign. If something goes wrong, and they overgrew and produced a lump, the cells are abnormal and can grow uncontrollably, they are cancerous cells, and the tumour is malignant. Benign tumour won't invade nearby tissues or spread to other areas of the body (metastasize). A benign tumour is less
worrisome unless it is pressing on nearby tissues, nerves, or blood vessels and causing damage.
Fibroids in the uterus or lipomas are examples of benign tumours. Malignant means that the tumour is made of cancer cells, and it can invade nearby tissues. Some cancer cells can move into the bloodstream or lymph nodes, where they can spread to other tissues within the body—this is called metastasis. Cancer can occur anywhere in the body including the breast, intestines, lungs,
reproductive organs, blood, and skin. The occurrence of cancer varies in different organs (Fig: 01)
Clinically, cancer appears to be many different diseases with different phenotypic characteristics.
As cancerous growth progresses, genetic drift in the cell population produces cell heterogeneity in such characteristics as cell antigenicity, invasiveness, metastatic potential, rate of cell proliferation, differentiation state, and response to chemotherapeutic agents. At the molecular
level, all cancers have several things in common, which suggests that the ultimate biochemical
lesions leading to malignant transformation and progression can be produced by a common but
not an identical pattern of alterations of gene readout. In general, malignant cancers cause significant
morbidity and will be lethal to the host if not treated
Angiosarcomas are rare and represent less than 2 percent of all sarcomas. The most frequently involved primary sites are heart, liver and breast with over 100 cases of each reported. Angiosarcomas of the lungs are usually metastasis. Differential diagnosis of vascular neoplasm metastatic to the lungs includes Kaposi sarcoma, epithelioid hemangioendothelioma, and angiosarcoma.
Primary angiosarcoma of the lung is extremely rare and is usually diagnosed quite late due to low index of suspicion.
Reported chest radiograph findings have ranged from normal to multiple nodular densities with or without pleural effusions to diffuse alveolar infiltrates compatible with pulmonary haemorrhage. Metastatic angiosarcoma lung lesions are commonly multiple. There have been reported as solid nodular or thin-walled cysts, with haemorrhagic change.
The HPE was consistent with an epithelioid angiosarcoma and this was also supported by positive reaction for factor VIII-related antigen, CD34 and CD31, which are specific markers for tumours derived from the endothelium.
Predisposing factors for angiosarcomas include polyvinyl chloride and thorium dioxide exposure, postmastectomy and postirradiation states (cutaneous angiosarcoma) and chronic empyema for pleural space angiosarcomas.
Cancer Awareness - Kaplan University Dept. of Public Healthsmtibor
Cancer awareness, including general definitions, detection, prevention, treatment, and risk factors. Emphasis on skin and prostate cancers and at-risk populations.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Cancer is an abnormal growth of cells caused by multiple changes in gene expression leading to
dysregulated balance of cell proliferation and cell death and ultimately evolving into a population
of cells that can invade tissues and metastasize to distant sites, causing significant morbidity and,
if untreated, death of the host.
It is characterized by alterations in the expression of multiple genes, leading to dysregulation of the normal cellular program for cell division and cell differentiation. This results in an imbalance of cell replication and cell death that favours the growth of a tumour cell population. Tumour is an abnormal lump or growth of cells. When the cells in the tumour are normal, it is benign. If something goes wrong, and they overgrew and produced a lump, the cells are abnormal and can grow uncontrollably, they are cancerous cells, and the tumour is malignant. Benign tumour won't invade nearby tissues or spread to other areas of the body (metastasize). A benign tumour is less
worrisome unless it is pressing on nearby tissues, nerves, or blood vessels and causing damage.
Fibroids in the uterus or lipomas are examples of benign tumours. Malignant means that the tumour is made of cancer cells, and it can invade nearby tissues. Some cancer cells can move into the bloodstream or lymph nodes, where they can spread to other tissues within the body—this is called metastasis. Cancer can occur anywhere in the body including the breast, intestines, lungs,
reproductive organs, blood, and skin. The occurrence of cancer varies in different organs (Fig: 01)
Clinically, cancer appears to be many different diseases with different phenotypic characteristics.
As cancerous growth progresses, genetic drift in the cell population produces cell heterogeneity in such characteristics as cell antigenicity, invasiveness, metastatic potential, rate of cell proliferation, differentiation state, and response to chemotherapeutic agents. At the molecular
level, all cancers have several things in common, which suggests that the ultimate biochemical
lesions leading to malignant transformation and progression can be produced by a common but
not an identical pattern of alterations of gene readout. In general, malignant cancers cause significant
morbidity and will be lethal to the host if not treated
Angiosarcomas are rare and represent less than 2 percent of all sarcomas. The most frequently involved primary sites are heart, liver and breast with over 100 cases of each reported. Angiosarcomas of the lungs are usually metastasis. Differential diagnosis of vascular neoplasm metastatic to the lungs includes Kaposi sarcoma, epithelioid hemangioendothelioma, and angiosarcoma.
Primary angiosarcoma of the lung is extremely rare and is usually diagnosed quite late due to low index of suspicion.
Reported chest radiograph findings have ranged from normal to multiple nodular densities with or without pleural effusions to diffuse alveolar infiltrates compatible with pulmonary haemorrhage. Metastatic angiosarcoma lung lesions are commonly multiple. There have been reported as solid nodular or thin-walled cysts, with haemorrhagic change.
The HPE was consistent with an epithelioid angiosarcoma and this was also supported by positive reaction for factor VIII-related antigen, CD34 and CD31, which are specific markers for tumours derived from the endothelium.
Predisposing factors for angiosarcomas include polyvinyl chloride and thorium dioxide exposure, postmastectomy and postirradiation states (cutaneous angiosarcoma) and chronic empyema for pleural space angiosarcomas.
Cancer Awareness - Kaplan University Dept. of Public Healthsmtibor
Cancer awareness, including general definitions, detection, prevention, treatment, and risk factors. Emphasis on skin and prostate cancers and at-risk populations.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.